It's not even your browser's fault.
The design flaw in Flowise’s Custom MCP node has allowed attackers to execute arbitrary JavaScript through unvalidated ...
Nexus Pharmaceuticals, LLC announces the launch of Cyclophosphamide Injection, available in ready to dilute 2.5 mL fill and 5 ...
Google on Wednesday released security updates for the Chrome web browser to address four vulnerabilities, including one that it said has been exploited in the wild. The zero-day vulnerability in ...
The widely used Axios HTTP client library, a JavaScript component used by developers, was recently hacked to distribute ...
The arrival of the Wegovy pill (semaglutide), the first oral GLP-1 drug approved to treat obesity, means freedom of choice: Adults who are looking to lose weight and have at least one weight-related ...
WCAG accessibility violations? Don't just detect them — fix them. A GitHub Action that scans your HTML for WCAG 2.2 violations and automatically fixes them in your source code. No overlays. No ...
While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Peptides have become a buzzy wellness trend, promoted ...
A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results